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Abstract 
Arylthiols were reacted with acrylonitrile under basic conditions to form the 
corresponding aryl sulfides which were oxidised with sodium metaperiodate 
in aqueous methanol to yield 3-arylsulphinylpropanenitriles that upon ther-
molysis in refluxing toluene produced a mixture of diarylthiosulfonates and 
diaryldisulfides. The mixture of the two products was easily separated by flash 
chromatography and characterized spectroscopically. The diarylthiosulfonates 
and diaryldisulfides, garlic-like organosulfur compounds, were tested for their 
antimicrobial properties against Escherichia coli, Pseudomonas aeruginosa, 
Staphylococcus aureus and Helicobacter pylori and had been found to have 
good activity against S. aureas and H. pylori with no activity against the other 
two organisms. 
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1. Introduction 
The medicinal properties of crushed garlic and onions are well recognized [1] 
[2]. The natural products in garlic responsible for the therapeutic actions are iden-
tified as the thiosulfinate esters alliin (S-allyl-L-cysteine sulfoxide) and allicin (di-
allylthiosulfinate) (Figure 1) which have been reported to have a broad range of 
biological activities such as for example anti-inflammatory [1] and antibacterial 
[3] [4] actions. 
In the laboratory synthetic versions of thiosulfinate esters have usually been 
made by either the oxidation of diaryldisulfides [5] [6] [7] [8] with peracids or 
by condensation of a sulfinyl chloride with a thiol in the presence of a tertiary 
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amine [8] [9] [10]. A third method which has been little used for making sym-
metrical diarylthiosulfinates involves the condensation of arylsulfenic acids gen-
erated in situ by thermolysis of arylsulfoxides possessing β-hydrogens. The β-eli- 
mination of sulfoxides to yield sulfenic acids and the condensation of sulfenic 
acids to form thiosulfinate esters are well documented in the literature [11] (Figure 
2).  
In our previously reported synthesis of phenylsulfinyl alkene derivatives by 
the Markovnikov addition of benzenesulfenic acid to terminal alkynes, generated 
in situ by thermolysis of 3-phenylsulfinylpropanenitrile [12] the diphenylthi-
osulfinate produced as a by-product was always disposed of. In this article, we 
report this synthetic strategy of making diarylthiosulfinates by condensation of 
arylsulfenic acids in the absence of any terminal alkynes as trapping agents.  
The antimicrobial activity of garlic is mainly due to the thiosulfinate ester called 
allicin and is reported to be three times more effective on Gram-positive bacteria 
than Gram-negative ones [13]. The antibacterial activity of aqueous garlic ex-
tract against 16 H. pylori strains has been assessed and MIC50 concentrations in 
the range 2 - 5 mg ml−1 were able to inhibit the strains. In most cases, the inhibi-
tory concentrations [4] were also bactericidal.  
Helicobacter pylori and its clinical association with the development of peptic 
ulcers has led to the development of various chemotherapeutic agents to elimi-
nate infection caused by this pathogen [14] [15] [16] [17] [18]. H. pylori is also 
implicated in the development of acute and chronic gastritis, gastric adenocar-
cinoma and gastric lymphoma (MALT), and has been classified as a class I car-
cinogen in humans and is a major contributing factor in the development of gas-
tric cancer [19]. Infection with H. pylori is typically treated with a combination 
of clartithromycin, ampicillin and a proton pump inhibitor, but this triple ther-
apy approach is costly [20]. The infection is eradicated in up to 90% of patients 
but side effects, poor compliance and the development of antimicrobial resis-
tance are common causes of treatment failure [21]. H. pylori infection has been 
implicated with increased COX-2 expression in gastric antral mucosa for both 
NSAID users and non-users [22] [23] [24]. We have been engaged with the search 
for compounds with anti-H. pylori activity and have recently reported anti-H. 
pylori activity of novel quinoline-derived propionic acid esters [25]. In this pa-
per, we report the synthesis and antimicrobial activities of a set of diaryl disul-
fides 6 and diaryl thiosulfonates 7. 
 
 
Figure 1. Enzymatic conversion of alliin into diallylthiosulfinate (allicin). 
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Figure 2. b-Elimination arylsulphoxides to produce sulphenic acids. 
 
Staphylococcus aureus is a versatile pathogen that can cause a range of infec-
tious diseases ranging from superficial skin infections to life-threatening septi-
caemia. The emergence of antibiotic-resistant strains of S. aureus including MRSA, 
VISA, LRSA and multi-drug resistant isolates has led to a great deal of interest in 
developing novel anti-staphylococcal agents [26] [27] [28].  
Escherichia coli is a common commensal organism in the human gastroin-
testinal tract but it is also a significant pathogen that can cause a range of 
human infections including diarrheal diseases and urinary tract infections through 
wound infections and life-threatening ulcerative colitis and septicaemia [29] 
[30]. 
Due to the structural similarity of our synthetic compounds 6 and 7 to thi-
osulfinate esters found in garlic, we decided to investigate their preliminary an-
timicrobial activity against Helicobacter pylori and a Gram-positive bacterium, 
Staphylococcus aureus (including resistant strains of this species), and the Gram- 
negative bacterium, Escherichia coli.  
2. Results and Discussion 
2.1. Chemistry 
Conjugate addition of thiolate anions to acrylonitrile furnished the arylsulfides 
2a-i and 2k-m in excellent date yields (93% - 98%) with 2j obtained in 82% 
yield. Sodium metaperiodate is a specific oxidising agent for converting sulfides 
into sulfoxides. Thus oxidation of the sulfides 2a-m with one-molar equivalent 
of sodium metaperiodate in aqueous methanol yielded the corresponding sul-
foxides 3a-m which were isolated in good yields (63% - 89%) and characterised 
spectroscopically. The FTIR spectra showed the >S=O absorbance at 1043 - 1093 
cm−1. Upon refluxing in toluene under nitrogen the sulfoxides 3a-m thermolized 
to furnish the disulfides 6a-m and diarythiosulfonates 7a-m as the only reaction 
products according to TLC analysis. The mixtures diaryldisulfides 6a-m and di-
arylthiosulfonates 7a-m were separated and isolated by flash chromatography 
(Scheme 1).  
Our disappointment in not obtaining the anticipated diarylthiosulfinates 5 as 
reaction products was shown by subsequent literature search that described di-
arylthiosulfinates 5 to be thermally unstable compounds due to the weak S-S 
bond (bond strength ~ 35 kcal) [31]. Thermolysis of the sulfoxides 3 initially 
generates arylsulfenic acids 4 which by virtue of their high reactivity condense to  
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Scheme 1. Synthesis of 1-arylsulphinyl-2-cyanoethanes 3 and their thermolysis to form products 
6 and 7. 
 
form diarylthiosulfinates 5 and water. Compounds of the formula RS(O)SR tend 
to be unstable and usually cannot be isolated. At the high temperature of the reac-
tion the weak sulfinyl-sulfide S-S bond cleaves homolytically to generate radical 
pairs [32]. The recombination of arylsulfinyl radicals then produces the isolated 
symmetrical product 6 (Scheme 2).  
The recombination of arylsulfinyl radicals did not produce any of the antic-
ipated α,α’-diaryldisulfoxide 8 as reaction product [33] [34] but instead pro-
duced the thiosulfonate 7 as the isolated reaction product. The only evidence to 
date for the existence of stable α,α-disulfoxides has been provided by bridged 
bicyclic compound 9 [35]. 
2.2. Microbiological Results and Discussion 
An increase in resistance of bacteria and fungi towards currently available anti-
bacterial and antifungal agents has resulted in a huge demand for the identifica-
tion of novel antimicrobial agents. This is due to the rapid development of anti-
microbial-resistant bacterial and fungal strains as well as a lack of new antimi-
crobial drugs that are effective against these resistant strains. Antimicrobial 
screening assays provide a robust method for the discovery of potential inhibi-
tors of microbial growth. Due to the structural similarity of our synthetic com-
pounds 6 and 7 to thiosulfinate esters found in garlic we decided to investigate 
their preliminary antimicrobial activity against Helicobacter pylori and a Gram- 
positive bacterium, Staphylococcus aureus (including resistant strains of this spe-
cies, and the Gram-negative bacterium, Escherichia coli. The diarylthiosulfonates 
7d, 7h, 7j, 7k, 7l and 7m and diaryldisulfides 6d, 6h, 6j, 6k, 6l and 6m were dis-
solved in 50% DMSO and tested for their antimicrobial activities using the broth 
microdilution method (Table 1). 
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Scheme 2. The disproportionation and recombination of thiol and arylsulfinyl radicals to 
form the products 7 and 8. 
 
Table 1. Antimicrobial activity of compounds 6a-f, 6h, 6j, 6k-m and 7b-e, 7g-h, 7j-l. 
Compound 
MIC (μg/ml) 
H. pylori 3339 
MIC (μg/ml) 
H. pylori 26695 
MIC (μg/ml) 
E. coli 
MIC (μg/ml) 
S. aureus 
6a   >256  
6b 64 32 >256 64 
6c 32 64   
6d 64 128   
6e 16 32 >256 >256 
6f   >256 >256 
6h 32 32 >256 4 
6j 16 32 >256 16 
6k 32 32 >256 8 
6l 16 64 >256 16 
6m 64 64   
7b 16 64 >256 32 
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Continued 
7c 16 32   
7d  32 >256 16 
7e 32 64 >256 128 
7g 16 16 >256 32 
7h 64 >128 >256 4 
7j 16 64 >256 32 
7k 16 32 >256 2 
7l 32 32 >256 >256 
Ampicillin 0.032 0.032 4 4 
Ciprofloxacin 0.5 0.5 0.06 0.25 
Tetracycline 1 1 1 1 
 
Although there was no antimicrobial activity of any of the compounds against 
the Gram-negative pathogen E. coli there was some very promising effect on the 
common Gram-positive pathogen S. aureus. Compounds 6 and 7 were signifi-
cantly inactive in antimicrobial activity against E. coli showing activity only at > 
256 μg/mL but displayed modest activity against the other two organisms H. py-
lori 3339 and S. aureus. All the derivatives 6e, 6j, 6l, 7b, 7c, 7g and 6g as a mix-
ture, 7j and 7k have shown modest antimicrobial activity against H. pylori 3339 
when compared with the standard anti-Helicobacter agents shown in Table 1. 
There is a noticeable common Structure-Activity Relationship (SAR) observed 
in inhibitory activity for the two different sets of compounds 6 and 7 on the H. 
pylori strain 3339. It was seen that when the aromatic rings in compounds 6 and 
7 are ortho- and para-substituted with -OMe, -Cl and -Br groups the compounds 
tend to have the lowest concentration inhibitory effects overall. On the other 
hand some of the compounds 6 and 7 have shown modest to good antimicrobial 
activity against S. aureus In particular the diaryldisulfides 6h, 6k and diarylthi-
osulfonates 7h and 7k gave the lowest inhibitory responses that are either equal 
or better than ampicillin. Thus, it is interesting to note that diarylthiosulfonate 
7k is the most active at 2 μg/mL whilst its counterpart diaryldisulfide 6k inhibits 
at a somewhat higher concentration of 8 μg/mL. Similarly the 2-chloro deriva-
tives of 6 and 7 showed good inhibitory action against S. aureus at 4 μg/mL. 
Thus, a noticeable structure-activity feature of the most promising four active 
compounds 6h, 6k, 7h and 7k is the presence of chloro- or bromo-groups in the 
2-position of the aromatic rings. We conclude that for good inhibitory activity 
against S. aureus compounds 6 and 7 require of an ortho-substituted chlorine or 
bromine atoms as best candidates for further antibacterial studies.  
3. Experimental 
3.1. General Methods 
Melting points are uncorrected and were determined on Stuart Scientific SMP3 
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apparatus. Infrared spectra were recorded with an ATI Mattson Genesis series 
FTIR spectrophotometer. 1H NMR and 13C NMR spectra were recorded in CDCl3 
using a Bruker AC 250 spectrometer operating at 250 and 62.9 MHz, respective-
ly. Chemical shifts (δ) are in ppm downfield from Me4Si as internal standard and 
J values are given in Hz. Mass spectra were recorded with EI-VG 7070E mass 
spectrometer. Accurate masses were determined on VG Autospec, EI mass spec-
trometer with magnetic sector instrument. 
3.2. Typical Experimental Procedure for the Formation of Sulfides  
2 a-m 
To a magnetically stirred solution of thiol 1 (0.10 mol) and acrylonitrile (20 ml, 
an excess) in THF (40 ml) at 0˚C was added a solution of tetrabutylammonium 
fluoride in THF (2 ml) and the mixture was allowed to stir and come to room 
temperature overnight. The solvent was rotary evaporated and the residue ex-
tracted with DCM (160 ml). The organic solution was washed with 2M NaOH 
solution (2 × 40 ml) and water (50 ml) before being dried over MgSO4 and eva-
porated to yield the crude sulfide 2 which according to TLC [1: 5 EtOAc-petrol] 
did not require any further purification. 2a [12], 2b: oil, 98% yield, IR ν 2248 
(CN) cm−1; 1HNMR δ 2.43 (3H, s, CH3), 2.56 (2H, t, J = 7.8 Hz, SCH2-), 3.10 
(2H, t, J = 7.8 Hz, -CH2CN), 7.10 - 7.40 (4H, m, Ar); MS m/z 177 (M+, 73%), 137 
(M-CH2CN, 100%); 2c: oil, 93% yield, IR ν 2248 (CN) cm−1; 1HNMR δ 2.35 (3H, 
s, CH3), 2.58 (2H, t, J = 7.8 Hz, SCH2-), 3.08 (2H, t, J = 7.8 Hz, -CH2CN), 7.03 - 
7.30 (4H, m, Ar); EIMS: m/z 177 (M+, 64%), 137 (M-CH2CN, 100%); 2d: oil, 
93% yield, IR ν 2248 (CN) cm−1; 1HNMR δ 2.37 (3H, s, CH3), 2.55 (2H, t, J = 7.8 
Hz, SCH2-), 3.10 (2H, t, J = 7.8 Hz, -CH2CN), 7.15 (2H, d, J = 7.5 Hz, AB system 
Ar), 7.34 (2H, d, J = 7.5 Hz, AB system Ar); EIMS: m/z 177 (M+, 64%), 137 
(M-CH2CN, 100%); 2e: oil, 98% yield, IR ν 2248 (CN) cm−1; 1HNMR δ 2.58 (2H, 
t, J = 7.8 Hz, SCH2-), 3.11 (2H, t, J = 7.8 Hz, -CH2CN), 3.90 (3H, s, OCH3), 6.83 - 
6.94 (2H, m, Ar); 7.23 - 7.40 (2H, m, Ar); EIMS: m/z 193 (M+, 100%), 153 
(M-CH2CN, 69%); 2f: oil, 98% yield, IR ν 2248 (CN) cm−1; 1HNMR δ 2.63 (2H, t, 
J = 7.8 Hz, SCH2-), 3.13 (2H, t, J = 7.8 Hz, -CH2CN), 3.80 (3H, s, OCH3), 6.80 
(1H, d, J = 7.5 Hz, Ar H-4); 6.88 - 7.00 (2H, m, Ar); (1H, t, J = 7.5 Hz, Ar H-5); 
EIMS: m/z 193 (M+, 100%), 153 (M-CH2CN, 68%), 140 (M-CH2CH2CN, 63%); 
2g: oil, 93% yield, IR ν 2248 (CN) cm−1; 1HNMR δ 2.52 (2H, t, J = 7.8 Hz, 
SCH2-), 2.98 (2H, t, J = 7.8 Hz, -CH2CN), 3.80 (3H, s, OCH3), 6.87 (2H, d, J = 7.5 
Hz, AB system Ar H-3 and H-5), 7.40 (2H, d, J = 7.5 Hz, AB system Ar H-2 and 
H-6); EIMS: m/z 193 (M+, 100%), 153 (M-CH2CN, 77%), 140 (M-CH2CH2CN, 
70%); 2h: oil, 98% yield, IR ν 2252 (CN) cm−1; 1HNMR δ 2.64 (2H, t, J = 7.8 Hz, 
SCH2-), 3.17 (2H, t, J = 7.8 Hz, -CH2CN), 7.15 - 7.30 (2H, m, Ar); 7.35 - 7.45 
(2H, m, Ar); EIMS: m/z 197.5 (M+, 52%), 157.5 (M-CH2CN, 100%); 2i: oil, 98% 
yield, IR ν 2252 (CN) cm−1; 1HNMR δ 2.63 (2H, t, J = 7.8 Hz, SCH2-), 3.12 (2H, t, 
J = 7.8 Hz, -CH2CN), 7.17 - 7.30 (3H, m, Ar), 7.37 (1H, s, Ar); EIMS: m/z 197.5 
(M+, 60%), 157.5 (M-CH2CN, 100%); 2j: oil, 82% yield, IR ν 2243 (CN) cm−1; 
1HNMR δ 2.58 (2H, t, J = 7.8 Hz, SCH2-), 3.12 (2H, t, J = 7.8 Hz, -CH2CN), 7.20 
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- 7.38 (4H, m, Ar); EIMS: m/z 197.5 (M+, 56%), 157.5 (M-CH2CN, 100%); 2k: 
oil, 98% yield, IR ν 2248 (CN) cm−1; 1HNMR δ 2.65 (2H, t, J = 7.8 Hz, SCH2-), 
3.18 (2H, t, J = 7.8 Hz, -CH2CN), 7.05 - 7.18 (1H, m, Ar); 7.20 - 7.50 (2H, m, Ar), 
7.52 - 7.67 (1H, m, Ar); EIMS: m/z 242 (M+, 37%), 202 (M-CH2CN, 100%); 2l: 
oil, 98% yield, IR ν 2243 (CN) cm−1; 1HNMR δ 2.57 (2H, t, J = 7.8 Hz, SCH2-), 
3.10 (2H, t, J = 7.8 Hz, -CH2CN), 7.26 (2H, d, J = 7.5Hz, AB system Ar), 7.45 
(2H, d, J = 7.5 Hz, AB system Ar); EIMS: m/z 242 (M+, 48%), 202 (M-CH2CN, 
51%); 2m: oil, 93% yield, IR ν 2248 (CN) cm−1; 1HNMR δ 2.60 (2H, t, J = 7.8 Hz, 
SCH2-), 3.20 (2H, t, J = 7.8 Hz, -CH2CN), 7.40 - 7.60 (3H, m, Ar); 7.72 - 7.95 
(4H, m, Ar); EIMS: m/z 213 (M+, 49%), 202 (M-CH2CN, 46%), 43 (100%).  
Typical experimental procedure for the formation of 3-arylsulfinylpropanenitriles 
3a-m: 
To a vigorously stirred solution of sodium metaperiodate (0.0763 mol) in wa-
ter (135 ml) at 0˚C was quickly added a solution of the sulfide 2 (0.0763 mol) in 
methanol (135 ml) and the mixture was stirred for 22h and allowed to come to 
RT. The precipitated inorganic solid was filtered at the pump and the mother 
liquor extracted with DCM (3 × 200 ml). After washing with water (100 ml) the 
organic layer was dried (MgSO4) and evaporated to yield the crude sulfoxide 3 
which was purified by flash chromatography [2:3 ethyl acetate-petrol followed 
by ethyl acetate]. 3a [12], 3b: 82% yield, IR ν 2246 (CN), 1035, 1068 (>S=O) 
cm−1; 1H NMR δ 2.30 (3H, s, CH3), 2.40 - 2.60 (1H, m, -CHCN), 2.75 - 2.93 (2H, 
m, -SO-CH2-), 3.05 - 3.22 (1H, m, -CHCN), 7.10 - 7.25 (1H, m, Ar), 7.30 - 7.45 
(2H, m, Ar), 7.67 - 7.80 (1H, m, Ar); EIMS: m/z 193 (M+, 29%), 140 (M-CH2= 
CH-CN, 46%), 139 (M-CH2CH2CN, 60%), 77 (100%); HRMS: Found 193.0565. 
Calcd. for C10H11NOS 193.0561; 3c: 85% yield, IR ν 2246 (CN), 1049, 1085 
(>S=O) cm−1; 1H NMR δ 2.36 (3H, s, CH3), 2.32 - 2.50 (1H, m, -CHCN), 2.72 - 
2.95 (2H, m, -SO-CH2-), 3.10 - 3.25 (1H, m, -CHCN), 7.20 - 7.40 (4H, m, Ar); 
EIMS: m/z 193 (M+, 14%), 140 (M-CH2=CH-CN, 16%), 139 (M-CH2CH2CN, 
67%), 66 (100%); HRMS: Found 193.0568. Calcd. for C10H11NOS 193.0561; 3d: 
76% yield, IR ν 2246 (CN), 1045, 1085 (> S=O) cm−1; 1H NMR δ 2.33 (3H, s, 
CH3), 2.27 - 2.50 (1H, m, -CHCN), 2.70 - 2.95 (2H, m, -SO-CH2-), 3.05 - 3.20 
(1H, m, -CHCN), 7.30 (2H, d, J = 7.5 Hz, AB system Ar), 7.43 (2H, d, J = 7.5 Hz, 
AB system Ar); EIMS: m/z 193 (M+, 13%), 140 (M-CH2=CH-CN, 23%), 139 
(M-CH2CH2CN, 100%), 91 (43%); HRMS: Found 193.0557. Calcd. for C10H11NOS 
193.0561; 3e: 65% yield, IR ν 2246 (CN), 1039, 1068 (>S=O) cm−1; 1H NMR δ 
2.25 - 2.45 (1H, m, -CHCN), 2.64 - 2.85 (1H, m, -SO-CH-), 2.97 - 3.13 (1H, m, 
-SOCH-), 3.15 - 3.34 (1H, m, -CHCN), 2.83 (3H, s, OCH3), 6.86 (1H, d, J = 7.5 
Hz, Ar), 7.10 (1H, t, J = 7.5 Hz, Ar), 7.43 (1H,t, J = 7.5 Hz, Ar), 7.60 (1H, d, J = 
7.5Hz, Ar); EIMS: m/z 209 (M+, 18%), 156 (M-CH2=CH-CN, 44%), 155 (M- 
CH2CH2CN, 100%); HRMS: Found 209.0517. Calcd. for C10H11NO2S 209.0510; 3f: 
89% yield, IR ν 2246 (CN), 1043 (>S=O) cm−1; 1H NMR δ 2.32 - 2.52 (1H, m, 
-CHCN), 2.67 - 2.94 (2H, m, -SO-CH2-), 3.05 - 3.22 (1H, m, -CHCN), 2.75 (3H, s, 
OCH3), 6.88 - 7.10 (3H, m, Ar), 7.28 - 7.43 (1H, t, J = 7.5 Hz, Ar); EIMS: m/z 209 
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(M+, 12%), 156 (M-CH2=CH-CN, 18%), 155 (M-CH2CH2CN, 65%); HRMS: 
Found 209.0515. Calcd for C10H11NO2S 209.0510; 3g: 89% yield, IR ν 2246 (CN), 
1043, 1087 (>S=O) cm−1; 1H NMR δ 2.38 - 2.53 (1H, m, -CHCN), 2.69 - 2.95 
(2H, m, -SO-CH2-), 3.03 - 3.17 (1H, m, -CHCN), 3.77 (3H, s, OCH3), 6.97 (2H, 
d, J = 7.5 Hz, AB system Ar), 7.47 (2H, d, J = 7.5 Hz, AB system Ar); EIMS: m/z 
209 (M+, 16%), 156 (M-CH2=CH-CN, 45%), 155 (M-CH2CH2CN, 100%); HRMS: 
Found 209.0509. Calcd for C10H11NO2S 209.0510; 3h: 86% yield, IR ν 2246 (CN), 
1043, 1087 (> S=O) cm−1; 1H NMR δ 2.38 - 2.40 (1H, m, -CHCN), 2.70 - 2.90 
(1H, m, -SO-CH-), 3.00 - 3.18 (1H, m, -SO-CH-), 3.22 - 3.42 (1H, m, -CHCN), 
7.30 - 7.60 (3H, m, Ar), 7.75 (1H, d, J = 7.5 Hz, Ar); EIMS: m/z 213.5 (M+, 38%), 
160.5 (M-CH2=CH-CN, 34%), 159.5 (M-CH2-CH2CN, 100%); HRMS: Found 
213.00146. Calcd for C9H8NSCl 213.0015 (Cl35); 3i: 73% yield, IR ν 2246 (CN), 
1051 (>S=O) cm−1; 1H NMR δ 2.40 - 2.58 (1H, m, -CHCN), 2.70 - 2.98 (2H, m, 
-SO-CH2-), 3.10 - 3.28 (1H, m, -CHCN), 7.33 - 7.47 (3H, m, Ar), 7.75 (1H, s, 
Ar); EIMS: m/z 213.5 (M+, 25%), 160.5 (M-CH2=CH-CN, 30%), 159.5 (M- 
CH2CH2CN, 100%); HRMS: Found 213.0016. Calcd for C9H8NSCl 213.0015 
(Cl35); 3j: 66% yield, IR ν 2246 (CN), 1047, 1081 (>S=O) cm−1; 1H NMR δ 2.40 - 
2.60 (1H, m, -CHCN), 2.74 - 2.98 (2H, m, -SO-CH2-), 3.10 - 3.28 (1H, m, 
-CHCN), 7.43 - 7.60 (4H, m, Ar); EIMS: m/z 213.5 (M+, 15%), 160.5 (M-CH2= 
CH-CN, 25%), 159.5 (M-CH2CH2CN, 100%); HRMS: Found 213.00146. Calcd 
for C9H8NSCl 213.0015 (Cl35); 3k: 63% yield, IR ν 2246 (CN), 1056, 1093 (>S=O) 
cm−1; 1H NMR δ 2.40 - 2.60 (1H, m, -CHCN), 2.76 - 2.98 (1H, m, -SO-CH-), 3.08 
- 3.25 (1H, m, -SO-CH-), 3.30 - 3.50 (1H, m, -CHCN), 7.42 (1H, t, J = 7.5 Hz, 
Ar), 7.50 - 7.65 (2H, m, Ar), 7.77 (1H, d, J = 7.5 Hz, Ar); EIMS: m/z 258 (M+, 
20%), 205 (M-CH2 = CH-CN, 29%), 204 (M-CH2CH2CN, 100%); HRMS: Found 
256.9516. Calcd for C9H8NSBr 256.9510 (Br79); 3l: 83% yield, IR ν 2246 (CN), 
1047, 1083 (>S=O) cm−1; 1H NMR δ 2.38 - 2.60 (1H, m, -CHCN), 2.74 - 2.97 
(2H, m, -SO-CH2-), 3.06 - 3.25 (1H, m, -CHCN), 7.44 (2H, d, J = 7.5 Hz, AB 
system Ar) 7.65 (2H, d, J = 7.5 Hz, AB system Ar); EIMS: m/z 258 (M+, 7%), 205 
(M-CH2=CH-CN, 58%), 204 (M-CH2CH2CN, 29%); HRMS: Found 256.9518. 
Calcd for C9H8NSBr 256.9510 (Br79); 3m: 74% yield, IR ν 2246 (CN), 1040, 1068 
(>S=O) cm−1; 1H NMR δ 2.35 - 2.53 (1H, m, -CHCN), 2.78 - 3.08 (2H, m, 
-SO-CH2-), 3.10 - 3.35 (1H, m, -CHCN), 7.37 - 7.70 (3H, m, Ar), 77.70 - 8.05 
(3H, m, Ar), 8.15 (1H, s, Ar); EIMS: m/z 229 (M+, 13%), 176 (M-CH2=CH-CN, 
35%), 175 (M-CH2CH2CN, 100%); HRMS: Found 229.0571 Calcd for C13H11NS 
229.0561. 
Typical experimental procedure for the formation of diaryldisulfides 6a-m 
and diarylthiosulfonates 7a-m: 
The sulfoxide 3 (0.03 mol) in dry toluene (80 ml) was heated at reflux under 
nitrogen for 2h after which the solvent was evaporated and the residue showing 
two spots by TLC [1:5 ethyl acetate-petrol] was separated by flash chromato-
graphy to yield firstly 6 followed by 7. 6a [12] and 7a [12]. 6b: 32% yield, oil, IR 
ν 1461, 1041, 1149 cm−1; 1H NMR δ 2.50 (6H, s, 2x CH3), 7.13 - 7.30 (6H, m, Ar), 
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7.55 - 7.65 (2H, d, J = 7.50 Hz, Ar); 13C NMR δ 20.85, 125.38, 126.05, 130.96, 
133.32, 142.08; EIMS: m/z 246 (M+, 83%), 123 (M – SC6H4-Me, 100%); HRMS: 
Calcd for C14H14S2 246.0537; Found 246.0530; 7b: 30% yield, oil, IR ν 1315, 1145 
cm−1; 1H NMR δ 2.15 (3H, s, CH3), 2.69 (3H, s, CH3), 7.02 - 7.50 (8H, m, Ar); 13C 
NMR δ 21.26, 21.64, 125.45, 126.10, 126.80, 128.25, 129.29, 131.24, 132.30, 
133.20, 133.58, 137.65, 139.18, 142.10; EIMS: m/z 278 (M+, 50%), 123 (M – 
SC6H4-Me, 85%); HRMS: Calcd for C14H14O2S2 278.04352; Found 278.04356; 6c: 
30% yield, oil, IR ν 1079, 1141 cm−1; 1H NMR δ 2.34 (6H, s, 2x CH3), 7.05 (2H, d, 
J = 7.80 Hz, Ar), 7.22 (2H, t, J = 7.80 Hz, Ar), 7.34 - 7.47 (4H, m, Ar); 13C NMR δ 
21.02, 124.22, 125.78, 126.75, 136.05, 140.59; EIMS: m/z 246 (M+, 100%), 123 (M 
– SC6H4-Me, 77%); HRMS: Found 246.0526. Calcd for C14H14S2 246.0537 7c: 24% 
yield, oil, IR ν 1318(-SO2), 1146 (S-O) cm−1; 1H NMR δ 2.30 (3H, s, CH3), 2.35 
(3H, s, CH3), 7.15 (2H, s, Ar), 7.20 - 7.45 (6H, m, Ar); 13C NMR δ 21.42, 124.99, 
128.28, 128.95, 129.49, 132.54, 133.89, 134.72, 13741, 137.42, 139.71, 143.42, 143.05; 
EIMS: m/z 278 (M+, 47%), 139 (SO2C6H4-Me, 100%); HRMS: Calcd for C14H14O2S2 
278.04352; Found 278.0447; 6d: 35% yield, mp 45˚C - 47˚C, IR ν 1340, 1116 
cm−1; 1H NMR δ 2.34 (6H, s, 2x CH3), 7.13 (4H, d, J = 7.80 Hz, AB system Ar), 
7.41 (4H, d, J = 7.80 Hz, AB system Ar), 13C NMR δ 21.48, 128.47, 129.70, 
133.85, 137.33; EIMS: m/z 246 (M+, 100%), 123 (M – SC6H4-Me, 86%); HRMS: 
Calcd for C14H14S2 246.0537; Found 246.05424; 7d: 36% yield, mp 82˚C - 84˚C, 
IR ν 1321 (-SO2), 1137 (S-O) cm−1; 1H NMR δ 2.38 (3H, s, CH3), 2.43 (3H, s, 
CH3), 7.07 - 7.30 (4H, m, Ar), 7.46 (2H, d, J = 7.80 Hz, Ar); 13C NMR δ 21.33, 
21.51, 124.44, 127.43, 129.25, 130.08, 136.32, 140.30, 141.93, 144.51; EIMS: m/z 
278 (M+, 48%), 139 (SO2C6H4-Me, 90%); HRMS: Calcd for C14H14O2S2 278.04352; 
Found 278.0447; 6e: 26% yield, mp 90˚C - 93˚C, IR ν 1238 cm−1; 1H NMR δ 3.91 
(6H, s, 2x CH3), 6.80 - 7.00 (4H, m, Ar), 7.13 - 7.30 (2H, m, Ar), 7.54 (2H, d, J = 
7.60 Hz, Ar); 13C NMR δ 56.25, 110.92, 121.70, 128.14, 138.68, 156.99; EIMS: m/z 
278 (M+, 82%), 139 (SC6H4-OMe, 100%); HRMS: Calcd. for C14H14O2S2 278.0435; 
Found 278.0440; 7e: 35.5% yield, mp 113˚C - 115˚C, IR ν 1247 (-SO2), 1095, 
1153 (S-O) cm−1; 1H NMR δ 3.82 (3H, s, CH3), 3.86 (3H, s, CH3), 6.85 (4H, t, J = 
7.80, Ar), 7.25 (2H, d, J = 7.80 Hz, Ar), 7.49 (2H, d, J = 7.80 Hz, Ar); 13C NMR δ 
55.82, 56.06, 114.32, 114.72, 115.26, 115.46, 130.14, 130.57, 138.15, 138.60, 
162.57, 163.92; EIMS: m/z 310 (M+, 44%), 177 (SO2C6H4-OMe, 22%), 155 (SOC6H4- 
OMe, 62%), 139 (SC6H4-OMe, 100%); HRMS: Calcd for C14H14O4S2 310.0333; 
Found 310.0344; 6f: 31% yield, oil, IR ν 1249, 1085,1152 cm−1; 1H NMR δ 3.79 
(6H, s, 2x CH3), 6.78 (2H, d, J = 7.80 Hz, Ar), 7.05 - 7.15 (4H, m, Ar), 7.23 (2H, 
d, J = 7.8 Hz, Ar); 13C NMR δ 55.84, 111.09, 114.16, 119.47, 137.02, 161.00; EIMS: 
m/z 278 (M+, 41%), 139 (M-SC6H4-OMe, 100%); HRMS: Calcd for C14H14O2S2 
278.0435; Found 278.0439; 7f: 45% yield, oil, IR ν 1286(-SO2), 1139,1183 (S-O) 
cm−1; 1H NMR δ 3.70 (6H, s, 2x OCH3), 6.80 - 7.38 (8H, m, Ar); 13C NMR δ 
55.85, 111.20, 112.19, 114.09, 119.36, 120.72, 121.63, 130.10, 130.62, 133.50, 139.64, 
160.06, 161.00; EIMS: m/z 310 (M+, 73%), 155 (SC6H4-OMe, 100%); HRMS: 
Calcd for C14H14O4S2 310.0333; Found 310.0340; 6g: 34% yield, oil, IR ν 1030, 
1171 cm−1; 1H NMR δ 3.81 (6H, s, 2x OCH3), 6.84 (4H, d, J = 7.75 Hz, AB system 
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Ar), 7.41 (4H, d, J = 7.75 Hz, AB system Ar); 13C NMR δ 55.90, 114.50, 128.54, 
130.21, 157.10; EIMS: m/z 278 (M+, 95%), 139 (SC6H4-OMe, 100%); HRMS: 
Calcd. for C14H14O2S2 278.0435; Found 278.0435; 7g: 31% yield, oil, IR ν 1288 
(-SO2), 1170, 1032 (S-O) cm−1; 1H NMR δ 3.75 (6H, s, 2x OCH3), 7.50 (4H, d, J = 
7.80 Hz, AB system Ar), 7.65 (4H, d, J = 7.80 Hz, AB system Ar); 13C NMR δ 
55.88, 114.64, 115.28, 124.90, 129.30, 130.37, 130.77, 130.81, 157.45, 165.72; 
EIMS: m/z 310 (M+, 60%), 155 (SC6H4-OMe, 100%); HRMS: Calcd. for C14H14O4S2 
310.0333; Found 310.0338; 6h: 41% yield, 88˚C - 90˚C, IR ν 1113, 1446 cm−1; 1H 
NMR δ 7.12 - 7.30 (4H, m, Ar), 7.38 (2H, d, J = 7.80 Hz, Ar), 7.56 (2H, d, J = 
7.80 Hz, Ar), 7.18 - 7.47 (4H, m, Ar), 7.48 - 7.70 (4H, m, Ar); 13C NMR δ 127.17, 
127.47, 127.73, 129.61, 131.80, 134.31; EIMS: m/z 286 (Cl35) (M+, 90%), 143 
(SC6H4-Cl35, 85%); HRMS: Calcd. for C12H8 S2Cl2 285.9444 (Cl35); Found 
285.9455; 7h: 37% yield, mp 157˚C - 160˚C, IR ν 1329(-SO2), 1147 (S-O) cm−1; 
1H NMR δ 7.08 - 7.30 (4H, m, Ar), 7.38 (2H, d, J = 7.80 Hz, Ar), 7.56 (2H, d, J = 
7.80 Hz, Ar); 13C NMR δ 126.54, 127.60, 130.19, 130.91, 132.36, 133.10, 134.76, 
139.72, 140.11, 140.21; EIMS: m/z 318 (Cl35) (M+, 30%), 175 (SO2C6H4-Cl35, 
35%), 143 (SC6H4-Cl35, 68%), 159 (SOC6H4-Cl35, 71%), 108 (100%); HRMS: 
Calcd. for C12H8O2 S2Cl2 317.9343 (Cl35); Found 317.9330; 6i: 31% yield, oil, IR ν 
1127, 1456 cm−1; 1H NMR δ 7.17 - 7.30 (4H, m, Ar), 7.30 - 7.42 (2H, m, Ar), 7.49 
(2H, s, Ar); 13C NMR δ 125.33, 125.59, 129.15, 13.58, 133.50, 137.38; EIMS: m/z 
286 (Cl35) (M+, 100%), 143 (SC6H4-Cl35, 78%); HRMS: Calcd. for C12H8 S2Cl2 
285.9444 (Cl35); Found 285.9455; 7i: 32% yield, oil, IR ν 1294 (-SO2), 1117 (S-O) 
cm−1; 1H NMR δ 7.16 - 7.65 (8H, m, Ar); 13C NMR δ 125.58, 126.39, 127.63, 
127.61, 129.10, 130.71, 131.20, 133.61, 133.82, 133.93, 135.36, 140.10; EIMS: m/z 
318 (Cl35) (M+, 41%), 159 (SO2C6H4-Cl35, 100%), 143 (SC6H4-Cl35, 64%); HRMS: 
Calcd. for C12H8O2 S2Cl2 317.9343 (Cl35); Found 317.9343; 6j: 53% yield, mp 70 - 
72˚C, IR ν 1151 cm−1; 1H NMR δ 7.28 (4H, d, J = 7.80 Hz, AB system Ar), 7.41 
(4H, d, J = 7.80 Hz, AB system Ar), 7.28 (2H, t, J = 7.80 Hz, Ar), 7.48 - 7.64 (4H, 
m, Ar); 13C NMR δ 129.15, 129.79, 133.51, 135.04; EIMS: m/z 286 (Cl35) (M+, 
86%), 143 (M-SC6H4-Cl35, 100%); HRMS: Calcd. for C12H8 S2Cl2 285.9444 (Cl35); 
Found 285.9451; 7j: 26%, mp 131˚C - 135˚C, IR ν 1322 (-SO2), 1107 (S-O) cm−1; 
1H NMR δ 7.25 - 7.39 (4H, m, Ar), 7.42 (2H, d, J = 7.80 Hz, AB system Ar), 7.52 
(2H, d, J = 7.80 Hz, Ar); 13C NMR δ 129.25, 129.60, 130.22, 130.71, 137.98, 
138.85, 140.87, 141.65; EIMS: m/z 318 (Cl35) (M+, 50%), 175(M-SC6H4-Cl35, 
85%), 143 (SC6H4-Cl35, 83%), 111 (100%); HRMS: Calcd. for C12H8O2 S2Cl2 
317.9343 (Cl35); Found 317.9345; 6k: 43% yield, 91˚C - 93˚C, IR ν 1357, 1151 
cm−1; 1H NMR δ 7.09 (2H, t, J = 7.80 Hz, Ar), 7.28 (2H, t, J = 7.80 Hz, Ar), 7.54 
(4H, d, J = 7.80 Hz, Ar); 13C NMR δ 121.00, 126.88, 127.83, 128.08, 132.80, 
136.06; EIMS: m/z 378 (Br81) (M+, 28%), 374 (Br79) (M+, 25%), 189 (SC6H4-Br81, 
18%), 187 (SC6H4-Br79, 17%); HRMS: Calcd. for C12H8 S2Br2 373.8434 (Br79); 
Found 373.8445; 7k: 35% yield, mp 138˚C - 140˚C, IR ν 1326 (-SO2), 1151 (S-O) 
cm−1; 1H NMR δ 7.24 - 7.47 (4H, m, Ar), 7.57 (2H, t, J = 7.80 Hz, Ar), 7.71 (1H, 
d, J = 7.80 Hz, Ar), 7.80 (1H, d, J = 7.80 Hz, Ar); 13C NMR δ 121.07, 121.25, 
127.18, 128.20, 128.95, 131.07, 131.22, 132.93, 133.52, 134.56, 135.95, 141.82; 
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EIMS: m/z 410 (Br81) (M+, 17%), 406 (Br79) (M+, 15%), 221 (SO2C6H4-Br81, 18%), 
219 (SO2C6H4-Br79, 19%), 205 (SOC6H4Br81, 64%), 203 (SOC6H4Br79, 61%), 108 
(100%); HRMS: Calcd. for C12H8 O2S2Br2 405.8332 (Br79); Found 405.8344; 6l: 
57% yield, 87˚C - 88˚C, IR ν 1149 cm−1; 1H NMR δ 7.34 (4H, d, J = 7.80 Hz, AB 
system Ar), 7.43 (4H, d, J = 7.80 Hz, AB system Ar); 13C NMR δ 121.43, 129.28, 
132.09, 135.62; EIMS: m/z 378 (Br81) (M+, 52%), 374 (Br79) (M+, 52%), 189 
(SC6H4-Br81, 60%), 187 (SC6H4-Br79, 57%); HRMS: Calcd for C12H8 S2Br2 373.8434 
(Br79); Found 373.8439; 7l: 28% yield, mp 105˚C - 107˚C, IR ν 1323 (-SO2), 1142 
(S-O) cm−1; 1H NMR δ 7.24 (2H, d, J = 7.80 Hz, AB system, Ar), 7.44 (2H, d, J = 
7.80 Hz, AB system, Ar), 7.52 (2H, d, J = 7.80 Hz, AB system Ar), 7.60 (2H, d, J 
= 7.80 Hz, AB system Ar); 13C NMR δ 126.49, 126.88, 128.82, 129.06, 132.10, 
132.78, 137.70, 141.75; EIMS: m/z 410 (Br81) (M+, 38%), 406 (Br79) (M+, 33%), 
221 (SC6H4-Br81, 52%), 199 (SC6H4-Br79, 51%), 108 (100%); HRMS: Calcd for 
C12H8 O2S2Br2 405.8332 (Br79); Found 405.8321; 6m: 46% yield,; IR ν 1149 cm−1; 
1H NMR δ 7.54 (2H, d, J = 7.80 Hz, H-3), 7.60 (4H, m, H-6, H-7), 7.86 (2H, s, 
H-1), 7.98 (4H, m, H-4, H-8), 8.06 (2H, d, J = 7.80 Hz, H-4); 13C NMR δ 126.58, 
126.90, 128.09, 128.55, 129.30, 129.63, 129.68, 129.76; EIMS: m/z 318 (M+, 48%), 
159 (SC10H7, 59%), 115 (100%); HRMS: Calcd. for C20H14S2 318.0537; Found 
318.0536; 7m: 40% yield, IR ν 1323(-SO2), 1124 (S-O) cm−1; 1H NMR δ 7.24 (1H, 
d, J = 7.80 Hz, H-3’), 7.60 (5H, m, H-1’, H-6, H-6’, H-7, H-7’), 7.85 (5H, m, H-4’, 
H-5, H-5’, H-8, H-8’), 8.15 (1H, d, J = 7.80 Hz, H-3), 8.38 (1H, d, J = 7.80 Hz, 
H-4), 8.85 (1H, s, H-1); 13C NMR δ 126.05, 126.60, 126.88, 127.06, 128.10, 
128.71, 129.30, 129.35, 129.41, 129.69, 129.80, 129.90, 130.2; EIMS: m/z 350 (M+, 
10%), 159 (SC10H7, 51%), 115 (100%); HRMS: Calcd for C20H14O2S2 350.0435; 
Found 350.0436.  
3.3. Microbiological Methods 
Microorganisms: E. coli (JM 109) and S. aureus (SH1000) control strains were 
used to test antimicrobial activity. The series of compounds 6 and 7 were dis-
solved in DMSO to produce various concentrations which were refrigerated.  
Inoculum: E. coli and S. aureus microorganisms were grown on Muller-Hinton 
Broth (MHB) for 24 hours at 37˚C. Starting innocula were prepared by di-
luting overnight cultures in fresh MHB to a culture density of 1 × 106 cfu/ml. 
Minimum Inhibitory Concentrations (MIC) were determined according to 
the BSAC broth microdilution MIC methodology described by Andrews (2001).  
4. Conclusion 
We have shown how diarylthiosulfonates and diaryldisulfides, garlic-like or-
ganosulphur compounds can be conveniently synthesised in two steps in good 
yields. These compounds were tested for their antimicrobial properties against 
Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Helico-
bacter pylori and had been found to have good activity against S. aureas and H. 
pylori with no activity against the other two organisms. SAR analysis of the re-
sults has shown the presence of chloro- or bromo-groups in the 2-position of the 
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aromatic rings to be crucial for antimicrobial activities. By SAR analysis the most 
promising four active compounds were 6h, 6k, 7h and 7k against Gram-positive 
organisms H. pylori and S. aureus. These compounds offer the promising pros-
pects for development into clinical candidates by further studies. 
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